The Role of Rifampin in Prosthetic Joint Infections: Efficacy, Challenges, and Clinical Evidence
Jakrapun Pupaibool · 2024
Read The Role of Rifampin in Prosthetic Joint Infections: Efficacy, Challenges, and Clinical Evidence by Jakrapun Pupaibool (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11727642.txt.
Description
Jakrapun Pupaibool reviews the antibiotic rifampin for infections in artificial joints in a 2024 paper. Such infections are hard to cure because bacteria form biofilms, slimy layers that shield them from drugs. Rifampin is valued because it can break into those layers.
The drug works well against staph bacteria and boosts partner drugs such as vancomycin. Some studies link it to better outcomes for patients. Yet strong human trial proof is scarce. The drug can clash with other medicines, and bacteria can grow resistant if care is sloppy. Pupaibool calls for more research to refine when and how the drug should be used.
Catalog record
| CREATOR | Jakrapun Pupaibool |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |